| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human Apc6 / CDC16 was used as the immunogen for the CDC16 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
CDC16 Antibody / Cell division cycle protein 16 is an antibody targeting CDC16. Host: Rabbit. Monoclonal. Clone: 31C86. Format: Liquid. Applications: WB, IP.
Key elements and design rationale
- Target: CDC16.
- Immunogen: A synthesized peptide derived from human Apc6 / CDC16 was used as the immunogen for the CDC16 antibody..
- Species reactivity: Human, Mouse, Rat.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
CDC16 antibody detects cell division cycle protein 16, a core component of the anaphase-promoting complex/cyclosome (APC/C). CDC16 belongs to the tetratricopeptide repeat (TPR) family of proteins, characterized by structural motifs that mediate protein-protein interactions.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.